Robert T. Schooley, MD is an infectious disease specialist and an expert in HIV and hepatitis C (HCV) infection and treatment. His research interests include influenza, global health, international medicine, and the diagnosis and management of infections that cause death and morbidity in resource-limited settings. He is particularly interested in the origin and development (pathogenesis) of HIV and HIV therapy, and was one of the first researchers to describe the humoral and cellular immune responses to HIV infection. Professor Schooley heads the Division of Infectious Diseases at UC San Diego School of Medicine, where he has developed a multidisciplinary research program for hepatitis C. Previously, while head of the Division of Infectious Diseases at University of Colorado and director of the Colorado Center for AIDS Research Virology Core Laboratory, he chaired the National Institute of Allergy and Infectious Diseases’ AIDS Clinical Trials Group. Before that, he was an associate professor of medicine at Harvard Medical School. Professor Schooley is extensively published, having edited numerous books and authored hundreds of articles and book chapters. He serves on the editorial board of several medical journals and in 2013 was honoured with the Best Doctors in America and America’s Top Doctors award.